Gannet Biochem

Nektar Therapeutics is one of the leading biopharmaceutical companies in the United States. The public company manufactures of a variety of therapeutics on the basis of advanced polymer conjugate chemistry technology platforms. Its research and development activities include small molecule drugs, peptides and other biological products. In addition, Nektar Therapeutics specializes in the areas of oncology, nephrology, pain, antiviral and immunology. The company s products help in improving the pharmacokinetics, pharmacodynamics, bioavailability, metabolism and distribution of drugs for patients. It offers a range of items under the Cimzia, Neulasta, DuraSeal, Macugen and Somavert brand names in the U.S. and Europe. Nektar Therapeutics operates a wholly owned subsidiary, Aerogen, Incorporated.